跳至主要内容
临床试验/NCT05367141
NCT05367141已完成不适用

Active (CDSS) Control Blinded Multicenter, Cluster-randomized Trial of the Adherence to Clinical Practice Guidelines Using the Clinical Decision Support System in Patients With Hypertension and Atrial Fibrillation (INTELLECT II Trial)

Samara Regional Cardiology Dispensary1 个研究点 分布在 1 个国家目标入组 282 人开始时间: 2022年5月17日最近更新:
适应症
干预措施

试验速览

阶段
不适用
状态
已完成
发起方
入组人数
282
试验地点
1
主要终点
Compliance with AF/hypertension clinical practice guidelines

研究概览

简要总结

The Clinical Decision Support Systems (CDSS) based on real clinical data and its own algorithms can help to make the right choice according to guidelines. The goal of the INTELLECT II study is to investigate treatment adherence to guidelines/science-based medicine and its impact on patient outcomes into two groups of doctors, clinical centers with standard care of treatment (control), and clinical centers using CDSS (active).

详细描述

Hypertension and atrial fibrillation are 2 important public health priorities. There is a gap between evidence-based best management and actual clinical practice. To decrease this gap, clinical practice guidelines (CPGs), based on available evidence are employed. Clinical decision support system ("MedicBK") is a computer-based program that analyzes published evidence and provides prompts and reminders to assist health care providers in implementing clinical guidelines and science-based medicine at the point of care. The INTELLECT II trial is designed as a multicenter, cluster-randomized, single-blind, controlled study with blinded outcome assessment. Approximately 10 centers from Russia will be enrolled. Centers managing patients with symptomatic atrial fibrillation and/or hypertension will be randomized to either patient management with aid of CDSS ("MedicBK") or standard care.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Supportive Care
盲法
Single (Outcomes Assessor)

入排标准

年龄范围
18 Years 至 90 Years(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Age > 18 years old
  • Patients diagnosed with nonvalvular atrial fibrillation and hypertension and indications for therapy according to European guidelines.

排除标准

  • Inability to adhere to study procedures
  • Severe heart-valve disorder
  • Stroke within 14 days or severe stroke within 6 months before screening
  • Active bleedings
  • Thyroid dysfunction
  • Pregnancy
  • Secondary hypertension

研究组 & 干预措施

CDSS

Active Comparator

patient management with aid of CDSS

干预措施: CDSS ("MedicBK") (Other)

standart care

No Intervention

patient management with standard care according to guidelines

结局指标

主要结局

Compliance with AF/hypertension clinical practice guidelines

时间窗: 1 month

number of patients treated in accordance with current ESC clinical guidelines for management atrial fibrillation evaluated by independent professionals compared with Clinical decision support system MedicBK

次要结局

  • Total cardiovascular events(6 months)
  • Total mortality(6 months)
  • total number of non-planing visits and hospitalization(6 months)

研究者

发起方
Samara Regional Cardiology Dispensary
申办方类型
Other
责任方
Principal Investigator
主要研究者

Prof. Dmitry Duplyakov FESC

Ass. Prof. Dmitry Duplyakov M.D.,Ph.D.

Samara Regional Cardiology Dispensary

研究点 (1)

Loading locations...

相似试验